Abstract:Fungal infections contribute to over 1.5 million fatalities each year, with cutaneous mycoses standing as prominent global infections. The spectrum of these mycoses varies widely, encompassing enduring afflictions like ringworm, localized infections such as tinea capitis, recurrent instances like vaginal candidiasis, and potentially fatal systemic infections impacting multiple organ systems. The escalating recognition of the health and socioeconomic ramifications associated with fungal pathogens underscores their importance in contemporary discourse. On a global scale, projections indicate that over 300 million individuals experience significant fungal infections annually, resulting in a mortality rate exceeding 1.5 million deaths per year. Alarmingly, resistance to commonly used antifungal drugs was on the rise, with some reports suggesting that over 10% of Candida bloodstream isolates worldwide were resistant to fluconazole, a commonly prescribed antifungal medication. Therefore, there is an immediate need to increase the accessibility of new antifungal medications while minimizing their costs and adverse effects. Fungi, as heterotrophic organisms, acquire nutrients through absorption. Their filamentous structure, composed of hyphae, facilitates efficient nutrient uptake by secreting enzymes that break down complex organic matter into simpler compounds. These organisms exhibit remarkable adaptability in responding to environmental cues, adjusting growth rates, and altering morphological features. Fungi regulate their metabolism intricately, undergoing various metabolic pathways for energy production and utilizing diverse substrates for respiration. Additionally, they exhibit distinctive reproductive strategies, employing both sexual and asexual modes of reproduction, contributing to their genetic diversity and resilience in diverse ecosystems. We now have more information than ever on the origins of infection as well as the physiology of fungi cells, giving us the chance to use it to produce new generations of antifungals. This review includes various novel antifungal drug targets showing their possible effects via different mechanisms aiming at vital functions like GPI synthesis, cell wall synthesis, hyphal growth, and other essential pathways responsible for fungal growth.

Special Issue: Novel Antifungal Drug Discovery

Use of Haploid Model of Candida Albicans to Uncover Mechanism of Action of a Novel Antifungal Agent.

New antifungal strategies: drug combination and co-delivery

Old and new strategies in therapy and diagnosis against fungal infections

Strategies in the Discovery of Novel Antifungal Scaffolds

Novel antifungal agents: a patent review (2011 - present)

Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

Synergistic Combinations of Antifungals and Anti-Virulence Agents to Fight Againstcandida Albicans

Antifungal Drug Resistance: An Emergent Health Threat

Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations

Investigational Agents for the Treatment of Resistant Yeasts and Molds

Antifungal drugs: What brings the future?

Advancements and challenges in antifungal therapeutic development

Drug repurposing strategies in the development of potential antifungal agents

Innovations in Antifungal Drug Discovery among Cell Envelope Synthesis Enzymes through Structural Insights

Exploring the Arsenal of Novel Antifungal Drug Targets for Combating Fungal Infections

Discovery of Natural Products With Antifungal Potential Through Combinatorial Synergy

Special Issue "Drug Discovery of Antiprotozoal Agents"

Worldwide emergence of resistance to antifungal drugs challenges human health and food security

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

From Synergy to Monotherapy: Discovery of Novel 2,4,6-Trisubstituted Triazine Hydrazone Derivatives with Potent Antifungal Potency In Vitro and In Vivo